Kiffik Biomedical

Kiffik Biomedical has developed a patented, wearable, non-invasive device that uses electroporation to continuously extract native interstitial fluid (ISF) for real-time biomarker monitoring. This enables high-frequency, painless molecular monitoring for diagnostics, clinical trials, and personalized medicine. The technology is positioned for both human and veterinary applications and is in advanced development, aiming for regulatory approval in the US and internationally. Kiffik has disclosed early clinical proof-of-concept, including glucose monitoring concordance between ISF and blood, and is advancing toward commercialization.